Sleep disturbances are associated with cortical and subcortical atrophy in alcohol use disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
16 08 2021
Historique:
received: 04 08 2020
accepted: 30 04 2021
revised: 20 04 2021
entrez: 17 8 2021
pubmed: 18 8 2021
medline: 12 10 2021
Statut: epublish

Résumé

Sleep disturbances are prominent in patients with alcohol use disorder (AUD) and predict relapse. So far, the mechanisms underlying sleep disruptions in AUD are poorly understood. Because sleep-related regions vastly overlap with regions, where patients with AUD showed pronounced grey matter (GM) reduction; we hypothesized that GM structure could contribute to sleep disturbances associated with chronic alcohol use. We combined sleep EEG recording and high-resolution structural brain imaging to examine the GM-sleep associations in 36 AUD vs. 26 healthy controls (HC). The patterns of GM-sleep associations differed for N3 vs. REM sleep and for AUD vs. HC. For cortical thickness (CT), CT-sleep associations were significant in AUD but not in HC and were lateralized such that lower CT in right hemisphere was associated with shorter N3, whereas in left hemisphere was associated with shorter REM sleep. For the GM density (GMD), we observed a more extensive positive GMD-N3 association in AUD (right orbitofrontal cortex, cerebellum, dorsal cingulate and occipital cortex) than in HC (right orbitofrontal cortex), and the GMD-REM association was positive in AUD (midline, motor and paralimbic regions) whereas negative in HC (the left supramarginal gyrus). GM structure mediated the effect of chronic alcohol use on the duration of N3 and the age by alcohol effect on REM sleep. Our findings provide evidence that sleep disturbances in AUD were associated with GM reductions. Targeting sleep-related regions might improve sleep in AUD and enhance sleep-induced benefits in cognition and emotional regulation for recovery.

Identifiants

pubmed: 34400604
doi: 10.1038/s41398-021-01534-0
pii: 10.1038/s41398-021-01534-0
pmc: PMC8368207
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

428

Subventions

Organisme : NIAAA NIH HHS
ID : R00 AA026892
Pays : United States

Informations de copyright

© 2021. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Nat Rev Neurosci. 2010 Feb;11(2):114-26
pubmed: 20046194
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Curr Biol. 2011 Dec 6;21(23):2029-32
pubmed: 22119526
J Clin Psychopharmacol. 1994 Aug;14(4):264-7
pubmed: 7962682
Trends Neurosci. 2017 May;40(5):309-323
pubmed: 28431742
JAMA Psychiatry. 2018 May 1;75(5):474-483
pubmed: 29541774
J Neurosci. 2010 Oct 6;30(40):13211-9
pubmed: 20926647
J Clin Sleep Med. 2017 Jun 15;13(6):791-803
pubmed: 28454598
Sleep Med. 2020 Nov;75:401-410
pubmed: 32957076
J Sleep Res. 2016 Dec;25(6):625-635
pubmed: 27252090
Lancet Psychiatry. 2014 Aug;1(3):202-12
pubmed: 26360732
JAMA Psychiatry. 2019 Jul 1;76(7):749-758
pubmed: 30942831
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6464-9
pubmed: 11353839
Sleep Med. 2014 Apr;15(4):401-9
pubmed: 24657204
Handb Clin Neurol. 2014;125:415-31
pubmed: 25307588
Neuroimage. 2017 Apr 15;150:250-261
pubmed: 28232191
Neuroreport. 2014 Mar 26;25(5):320-3
pubmed: 24346259
Biol Psychiatry. 2013 Nov 15;74(10):777-85
pubmed: 23601854
Alcohol Clin Exp Res. 2007 Jan;31(1):19-27
pubmed: 17207097
Neuron. 2011 Apr 14;70(1):153-69
pubmed: 21482364
Sleep. 2016 Jan 01;39(1):161-71
pubmed: 26414892
Brain Res. 1997 Oct 3;770(1-2):192-201
pubmed: 9372219
J Neurosci. 2017 May 17;37(20):5065-5073
pubmed: 28432144
Acta Psychiatr Scand Suppl. 1978;(274):33-9
pubmed: 216235
Brain Cogn. 2003 Nov;53(2):193-6
pubmed: 14607146
Neuroimage. 2019 Oct 15;200:313-331
pubmed: 31229660
Nat Neurosci. 2013 Mar;16(3):357-64
pubmed: 23354332
J Cogn Neurosci. 2010 Aug;22(8):1637-48
pubmed: 19702469
Am J Respir Crit Care Med. 1994 Aug;150(2):469-74
pubmed: 8049831
Sleep. 2019 Oct 21;42(11):
pubmed: 31328786
J Neurosci. 2015 May 20;35(20):7795-807
pubmed: 25995467
Front Neurol. 2019 Apr 05;10:312
pubmed: 31024418
Sleep. 1995 Sep;18(7):570-80
pubmed: 8552928
Alcohol Clin Exp Res. 2004 May;28(5 Suppl):48S-56S
pubmed: 15166636
Mov Disord. 2015 Apr 15;30(5):680-7
pubmed: 24676967
Alcohol Clin Exp Res. 1998 Nov;22(8):1864-71
pubmed: 9835309
Chest. 2008 Feb;133(2):427-32
pubmed: 17925420
Biol Psychiatry. 2008 Aug 1;64(3):192-202
pubmed: 18374900
Int J Neuropsychopharmacol. 2019 Sep 1;22(9):548-559
pubmed: 31369670
Neurosci Lett. 1999 Aug 27;271(3):139-42
pubmed: 10507688
Cereb Cortex. 2018 Feb 1;28(2):658-671
pubmed: 28591814
Sleep. 2019 Jun 11;42(6):
pubmed: 30860593
J Clin Sleep Med. 2016 Nov 15;12(11):1443-1451
pubmed: 27707438
J Gen Psychol. 2006 Oct;133(4):453-67
pubmed: 17128962
Psychiatry Res. 2015 Aug 30;233(2):125-30
pubmed: 26078198
J Neurophysiol. 2002 Nov;88(5):2280-6
pubmed: 12424269
Neuron. 2002 Sep 26;36(1):159-70
pubmed: 12367514
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
J Cereb Blood Flow Metab. 1991 May;11(3):502-7
pubmed: 2016359
Neuroscience. 2010 Mar 17;166(2):698-711
pubmed: 20036719
Hum Brain Mapp. 2016 Jun;37(6):2276-92
pubmed: 26947584
Am J Addict. 2010 May-Jun;19(3):238-44
pubmed: 20525030
Sleep Med Rev. 2009 Oct;13(5):363-77
pubmed: 19345124
Transl Psychiatry. 2014 Apr 08;4:e378
pubmed: 24713859
Transl Psychiatry. 2017 Dec 11;7(12):1279
pubmed: 29225356
Transl Psychiatry. 2019 Feb 11;9(1):78
pubmed: 30741945
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1608-13
pubmed: 19164756
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15160-5
pubmed: 18815373
J Sleep Res. 2000 Sep;9(3):207-31
pubmed: 11012860
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Clin Neurophysiol. 2000 May;111(5):924-8
pubmed: 10802465
Radiology. 2000 Sep;216(3):891-9
pubmed: 10966728
J Sleep Res. 2014 Apr;23(2):211-21
pubmed: 24313630
Curr Biol. 2019 Jul 22;29(14):2351-2358.e4
pubmed: 31303489
Neuroimage. 2009 Nov 1;48(2):371-80
pubmed: 19559801
J Neurosci. 2020 Jul 15;40(29):5589-5603
pubmed: 32541070
Sleep Med. 2013 Nov;14(11):1199-207
pubmed: 24047533
Nature. 1996 Sep 12;383(6596):163-6
pubmed: 8774879
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
Sleep. 2020 Oct 13;43(10):
pubmed: 32333599
Brain Struct Funct. 2018 Mar;223(2):669-685
pubmed: 28913599
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494
Brain Topogr. 1993 Winter;6(2):123-9
pubmed: 8123427
J Neurosci. 1997 Jun 15;17(12):4800-8
pubmed: 9169538
J Neurosci. 2008 Apr 2;28(14):3586-94
pubmed: 18385317
Neuropsychopharmacology. 2020 Jan;45(1):141-165
pubmed: 31234199
Sleep. 2010 Feb;33(2):235-41
pubmed: 20175407
World J Biol Psychiatry. 2010 Jun;11 Suppl 1:22-8
pubmed: 20509829
Am J Psychiatry. 2019 Feb 1;176(2):119-128
pubmed: 30336705
Neuroimage. 2013 Dec;83:658-68
pubmed: 23770411
J Neurosci. 2004 Aug 4;24(31):6862-70
pubmed: 15295020
Ann Neurol. 1999 Apr;45(4):430-8
pubmed: 10211466
Clin Geriatr Med. 2014 Aug;30(3):629-54
pubmed: 25037298
Biol Psychiatry. 2002 Aug 1;52(3):236-42
pubmed: 12182929

Auteurs

Rui Zhang (R)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA. rui.zhang@nih.gov.

Dardo Tomasi (D)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Peter Manza (P)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Ehsan Shokri-Kojori (E)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Sukru B Demiral (SB)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.
Walter Reed Army Institute of Research, 503 Robert Grant Ave, Silver Spring, MD, 20910, USA.

Dana E Feldman (DE)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Danielle S Kroll (DS)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Catherine L Biesecker (CL)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Katherine L McPherson (KL)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Gene-Jack Wang (GJ)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA.

Corinde E Wiers (CE)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA. corinde.wiers@nih.gov.

Nora D Volkow (ND)

National Institute on Alcohol Abuse and Alcoholism, Laboratory of Neuroimaging, National Institutes of Health, Bethesda, MD, 20892-1013, USA. nvolkow@nida.nih.gov.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892-1013, USA. nvolkow@nida.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH